Business

BELLUS Health to host webcast on chronic cough and treatment approach on September 20, 2017

BELLUS Health to host webcast on chronic cough and treatment approach on September 20, 201...

articleBluenergies Ltd.September 6, 20173/company/bluenergies-ltd/news/bellus-health-to-host-webcast-on-chronic-cough-and-treatment-approach-on-september-20-2017
BELLUS Health to host webcast on chronic cough and treatment approach on September 20, 2017

About this update from Bluenergies Ltd.

[{"type":"text","content":"\n\n\n\nBELLUS Health to host webcast on chronic cough and treatment approach on September 20, 2017\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n\n\n\n\n\n\n\nCanada NewsWire\nLAVAL, QC, Sept. 6, 2017\n\n\n\n- Key Opinion Leader Dr. Jacky Smith to present on chronic cough -- Company will also present an update on BLU-5937, a novel drug candidate for chronic cough -\n\n\n\nLAVAL, QC, Sept. 6, 2017 /CNW/ - BELLUS Health Inc. (TSX: BLU) (BELLUS Health or the Company), a biopharmaceutical development company advancing novel therapeutics for conditions with high unmet medical need, will host a Key Opinion Leader (KOL) event focused on the treatment of chronic cough. The Company will also present an update, including recent preclinical study results, on its chronic cough drug candidate, BLU-5937. The event will be webcast live on Wednesday September 20, 2017 at 2:00 pm Eastern Time.\n\nThe event will feature a presentation by KOL Dr. Jacky Smith, Professor of Respiratory Medicine at the University of Manchester and Director of the NIHR South Manchester Respiratory and Allergy Clinical Research Facility. Dr. Smith will discuss the clinical presentation of chronic cough, its current unmet medical need and therapeutic options as well as novel treatment approaches under development. \n\nDr. Denis Garceau, BELLUS Health's Senior Vice President, Drug Development, will also provide an update on BLU-5937, including results from preclinical studies and its development path.  \n\nBoth Dr. Smith and Dr. Garceau will be available to answer questions at the end of their presentations.\n\nTo listen to the live webcast or to ask questions during the live event, please register at the following link: https://event.webcasts.com/starthere.jsp?ei=1159556&tp_key=4a0ae58b66. To ensure a timely connection to the webcast, it is recommended that listeners pre-register no later than 15 minutes prior to the scheduled start time.  An archived version of the webcast and presentation will be available on the Company's website at www.bellushealth.com following the even...

More updates from Bluenergies Ltd.